Big Pharma Is a Pointless Target for Warren

What's not to like about sticking it to big, rich pharmaceutical firms in order to fund more of the government research that makes them rich? Who could be against that? So glad you asked.

Moving toward the base.

Photographer: Andrew Harrer/Bloomberg

Senator Elizabeth Warren has a modest proposal for pharmaceutical companies that get fined by the Food and Drug Administration for rule violations: a sort of "swear jar" that will require them to give money to the National Institutes of Health every time they break the FDA's rules. Peter Sullivan at the Hill reports:

To continue reading this article you must be a Bloomberg Professional Service Subscriber.